title: Regulating DeltaFosB expression in adult Tet-Off-DeltaFosB transgenic mice alters bone formation and bone mass.
abstract: The DeltaFosB isoforms are naturally occurring AP-1 family members that increase bone volume via a cell-autonomous effect on osteoblastic bone formation. Mice overexpressing DeltaFosB demonstrate a very high level of bone formation, resulting in a progressive osteosclerosis. Despite the linkage of bone formation and resorption in physiological systems, no alteration in bone resorption was detected in mice overexpressing DeltaFosB. To determine whether altering DeltaFosB expression can regulate bone formation independently of bone resorption in adult mice, we used the Tet-Off-inducible transgene system to induce or block transgenic DeltaFosB overexpression and thereby regulate bone formation in vivo. Overexpression of DeltaFosB after skeletal maturity increased trabecular bone volume by increasing bone formation, again without altering bone resorption, indicating that developmental DeltaFosB overexpression is not required for the osteosclerotic phenotype. Similarly, switching off DeltaFosB overexpression after osteosclerosis had developed led to a marked decrease in bone formation and loss of bone mass such that trabecular bone volume approached normal levels. Despite this dramatic reduction, no alteration in bone resorption was detected. These results clearly demonstrate that DeltaFosB regulates bone formation and bone mass in adult mice with no effect on bone resorption.
authors.affiliation: Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520-8044, USA.
authors.forename: N A
authors.initials: NA
authors.lastname: Sims
authors.forename: G
authors.initials: G
authors.lastname: Sabatakos
authors.forename: J-S
authors.initials: JS
authors.lastname: Chen
authors.forename: M B
authors.initials: MB
authors.lastname: Kelz
authors.forename: E J
authors.initials: EJ
authors.lastname: Nestler
authors.forename: R
authors.initials: R
authors.lastname: Baron
mesh_terms: D000818:Animals; D015519:Bone Density / Q000235:genetics*; D001862:Bone Resorption / Q000235:genetics; D004318:Doxycycline / Q000494:pharmacology; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D051379:Mice; D008822:Mice, Transgenic; D010012:Osteogenesis / Q000235:genetics*; D010026:Osteosclerosis / Q000235:genetics / Q000517:prevention & control; D010052:Ovariectomy; D016760:Proto-Oncogene Proteins c-fos / Q000235:genetics*; D013752:Tetracycline / Q000494:pharmacology; D018808:Transcription Factor AP-1 / Q000235:genetics
chemical_list: D016760:Proto-Oncogene Proteins c-fos; D018808:Transcription Factor AP-1; D013752:Tetracycline; D004318:Doxycycline